EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD

Kaan Zıkşahna, Murat Ihlamur

Journal of Gastroenterology · 28.10.2026

DOI: 10.1007/s00535-026-02531-0 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Gastroenterology, online erschienen am 28.10.2026. Verfasst von Kaan Zıkşahna und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Medicine, Biruni University, Istanbul, Turkey. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bifidobacterium bifidumKlebsiella pneumoniaeMetabolic dysfunction-associated steatotic liver disease (MASLD)Microbial secretomeProbiotic colonization

Autor:innen und Institutionen

  • Department of Basic Medical Sciences, Faculty of Medicine, Biruni University, Istanbul, Turkey.
  • Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkey.
  • Department of Electronics and Automation, Vocational School, Biruni University, Istanbul, Turkey. mihlamur@biruni.edu.tr.
  • Biruni University Advanced Technology and Research Center (B@MER), Biruni University, Istanbul, Turkey. mihlamur@biruni.edu.tr.

Zitieren

APA

Zıkşahna, K., & Ihlamur, M. (2026). Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02531-0

Vancouver

Zıkşahna K, Ihlamur M. Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02531-0

BibTeX
@article{Zkahna2026,
  author = {Zıkşahna, Kaan and Ihlamur, Murat},
  title = {Beyond fecal abundance: defining the active therapeutic entity in Bifidobacterium-mediated protection against Klebsiella-driven MASLD},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02531-0}
}
Kostenlos starten →